Savara Stock (NASDAQ: SVRA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 249.00 / 1.73M |
Day Range | - - - |
52 Wk Range | 3.12 - 5.70 |
Market Cap | $781.07M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 6.32% |
Days to Cover | 1.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Other companies in Savara’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Replimune Group (NASDAQ:REPL).
There is no analysis for Savara.
Savara has a consensus price target of $9.71.
The stock price for Savara (NASDAQ: SVRA) is $4.75 last updated Today at July 23, 2024 at 5:55 AM EDT.
There are no upcoming dividends for Savara.
Savara’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Savara.
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.